The possible benefits and limits of artificially generated data in the context of healthcare analytics.
MEP Action Group Meets in Brussels to Discuss Regulatory Pathways for Psychedelics – Psychedelic Alpha
Next, Maryam Jabir shared her experience as a participant in a phase 2b study of psilocybin therapy for treatment-resistant depression. Having struggled with depression for